Genetic Technologies Ltd. (NASDAQ: GENE) is a promising Australian biotech player that has made remarkable strides in the realm of genetic testing and risk identification.
Xenetic Biosciences Inc. (XBIO) stock plunged -15.46% to $2.68 in the pre-market trading following the company’s announcement of $6.0 million registered direct offering priced at-the-market
It’s a mixed day for the U.S equity markets. The markets rallied in the morning, but have since shed most of those gains. The DOW
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.